PubRank

Cécile Tremblay

Author PubWeight™ 35.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J Immunol 2009 1.52
2 CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 2012 1.28
3 Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers. PLoS One 2013 1.08
4 HIV infection and subclinical coronary atherosclerosis. Ann Intern Med 2014 1.07
5 Low prevalence of detectable HIV plasma viremia in patients treated with antiretroviral therapy in Burkina Faso and Mali. J Acquir Immune Defic Syndr 2008 1.06
6 Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. J Infect Dis 2004 1.03
7 HIV-associated lipodystrophy syndrome: A review of clinical aspects. Can J Infect Dis Med Microbiol 2005 1.02
8 HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease. J Infect Dis 2009 1.02
9 Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J Infect Dis 2004 0.98
10 Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression. Clin Immunol 2007 0.98
11 Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol 2005 0.96
12 Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. J Infect Dis 2003 0.95
13 Clinical prediction and diagnosis of neurosyphilis in HIV-infected patients with early Syphilis. J Clin Microbiol 2013 0.94
14 Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms. PLoS One 2013 0.93
15 IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication. J Leukoc Biol 2010 0.93
16 HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load. Clin Immunol 2009 0.91
17 HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. J Infect Dis 2010 0.91
18 Evaluation of a real-time virtual intervention to empower persons living with HIV to use therapy self-management: study protocol for an online randomized controlled trial. Trials 2012 0.89
19 The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection. AIDS 2016 0.89
20 The colocalization potential of HIV-specific CD8+ and CD4+ T-cells is mediated by integrin β7 but not CCR6 and regulated by retinoic acid. PLoS One 2012 0.88
21 Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals. Can J Infect Dis Med Microbiol 2007 0.88
22 Carbapenem disks on MacConkey agar in screening methods for detection of carbapenem-resistant Gram-negative rods in stools. J Clin Microbiol 2012 0.88
23 Potential role of IL-18 in the immunopathogenesis of AIDS, HIV-associated lipodystrophy and related clinical conditions. Curr HIV Res 2010 0.87
24 Role of interleukin-18 in the development and pathogenesis of AIDS. AIDS Rev 2009 0.86
25 Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 2009 0.85
26 Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication. Retrovirology 2013 0.85
27 Changes in function of HIV-specific T-cell responses with increasing time from infection. Viral Immunol 2010 0.85
28 Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options. Sex Transm Infect 2011 0.85
29 Virtual intervention to support self-management of antiretroviral therapy among people living with HIV. J Med Internet Res 2015 0.83
30 Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression. J Acquir Immune Defic Syndr 2015 0.81
31 Psychosocial profile and lived experience of HIV-infected long-term nonprogressors: a mixed method study. J Assoc Nurses AIDS Care 2014 0.81
32 Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells. J Virol 2009 0.81
33 Acceptability and feasibility of a virtual intervention to help people living with HIV manage their daily therapies. J Telemed Telecare 2012 0.79
34 Pandemic influenza A (H1N1) 2009: chest radiographic findings from 147 proven cases in the Montreal area. Can Assoc Radiol J 2010 0.79
35 Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adults. Can J Infect Dis Med Microbiol 2010 0.78
36 Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles. Viral Immunol 2011 0.78
37 Sexual behaviour after antiretroviral therapy initiation in female sex workers and HIV-positive patients from the general population, Cotonou, Benin. AIDS Care 2013 0.78
38 Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals. Can J Infect Dis Med Microbiol 2011 0.75
39 Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelines. Can J Infect Dis Med Microbiol 2009 0.75
40 CTX-M-15 type ESBL-producing Salmonella Havana associated with international adoption in Canada. Can J Microbiol 2012 0.75
41 First documented case of human infection with ovine Shiga-toxin-producing Escherichia coli serotype O52:H45. Can J Microbiol 2014 0.75
42 Incidence and risk factors for recurrent sexually transmitted infections among men who have sex with men on HIV pre-exposure prophylaxis. AIDS 2022 0.75